A board-certified internist, Dr. Daniel Knecht currently serves as Vice President, Transformation Clinical Product at CVS Health. He is responsible for clinical product ideation, concept development and testing, optimization, launch, performance and measurement in collaboration with key stakeholders across the enterprise.
Prior to this, he served as Vice President of Health Strategy and Innovation, Medical Affairs, where he worked across all major CVS Health business lines to develop and execute clinical strategies that address unmet health needs. He joined Aetna in 2016 and has led a series of enterprise-wide strategic initiatives including the company’s efforts to combat opioid misuse and addiction. Following CVS Health’s acquisition of Aetna, his team remained focused on leveraging data analytics to provide actionable insights for patients and providers that increase value of care.
A Fulbright scholar, Dr. Knecht has developed deep insights into the health care industry through a career encompassing life science entrepreneurship, strategy consulting, patient care and bench research. He graduated with honors from Dartmouth College and received a joint M.D., M.B.A., from Weill Cornell Medical College and Johnson Graduate School of Management where he was a recipient of the Lee Family Scholarship. He also is an associate clinical professor at Mount Sinai West in New York City where he still sees patients.
Have Questions? Contact Us
Transfers, Cancellations and Refunds Policy
Registrants may transfer their registration to another person at any time by notifying Lis Diaz (email@example.com) in writing. Cancellations must be made in writing to Lindsey Beck (firstname.lastname@example.org). Refunds minus a 20% service charge are available for cancellations received in writing 45 days or more prior to the start of the conference. No refunds are available thereafter.
Note: In the event the conference is cancelled because of COVID-19, refunds minus standard credit card transaction fees will be available.